ALX Oncology Holdings Inc. (ALXO)
ALXO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.9796
-22.25% on the day
Market cap
$135.5M
Micro cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ALXO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001810182 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2022-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-01-30 |
| Latest annual report | 10-K | 2026-03-09 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEF 14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 419 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ANTX | AN2 Therapeutics Inc. | $3.60 | -16.28% | $135.9M |
| RNA | Atrium Therapeutics Inc. | $7.75 | -5.60% | $132.6M |
| TLSA | Tiziana Life Sciences Ltd. Common Shares | $1.09 | 0.00% | $138.7M |
| BGM | BGM Group Ltd. | $10.48 | +2.75% | $140.0M |
| KRRO | Korro Bio Inc. | $8.81 | -5.98% | $129.7M |
| OGI | Organigram Global Inc. Common Shares | $0.9190 | -1.68% | $129.6M |
| CUE | Cue Biopharma Inc. | $19.57 | -20.48% | $142.2M |
| KZIA | Kazia Therapeutics Limited | $8.04 | -8.74% | $125.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier